Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy BriaCell Therapeutics (BCTX) stocks in Canada

Learn how to easily invest in BriaCell Therapeutics stocks.

BriaCell Therapeutics is a biotechnology business based in the US. BriaCell Therapeutics stocks (BCTX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $6.03 – an increase of 2.1% over the previous week. BriaCell Therapeutics employs 5 staff and has a market cap (total outstanding stock value) of $134.7 million.

How to buy shares in BriaCell Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BCTX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Is it a good time to buy BriaCell Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

How has Coronavirus impacted BriaCell Therapeutics's stock price?

Since the stock market crash in March caused by coronavirus, BriaCell Therapeutics's stock price has had significant negative movement.

Its last market close was $8.26, which is 52.50% down on its pre-crash value of $17.39 and 43.65% up on the lowest point reached during the March crash when the stocks fell as low as $5.75.

If you had bought $1,000 worth of BriaCell Therapeutics stocks at the start of February 2020, those stocks would have been worth $0.00 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $435.88.

BriaCell Therapeutics stock price (NASDAQ:BCTX)

Use our graph to track the performance of BCTX stocks over time.

BriaCell Therapeutics shares at a glance

Information last updated 2022-01-18.
Latest market close$8.26
52-week range$2.81 - $12.47
50-day moving average $9.12
200-day moving average $6.47
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.29

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.

Compare up to 4 providers

Online stock trading

BriaCell Therapeutics price performance over time

Historical closes compared with the close of $8.26 from 2022-01-18

1 week (2022-01-12) 2.10%
1 month (2021-12-17) -3.50%
3 months (2021-10-19) 5.22%
6 months (2021-07-19) 83.15%
1 year (2021-01-19) 50.18%
2 years (2020-01-17) -32.30%
3 years (2019-01-16) 12,928.39%
5 years (2017-01-18) 5,596.55%

BriaCell Therapeutics financials

Gross profit TTM $0
Return on assets TTM -19.6%
Return on equity TTM -9.2%
Profit margin 0%
Book value $3.60
Market capitalisation $134.7 million

TTM: trailing 12 months

BriaCell Therapeutics share dividends

We're not expecting BriaCell Therapeutics to pay a dividend over the next 12 months.

Have BriaCell Therapeutics's shares ever split?

BriaCell Therapeutics's shares were split on a 1:300 basis on 2 January 2020. So if you had owned 300 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BriaCell Therapeutics shares – just the quantity. However, indirectly, the new 29900% higher share price could have impacted the market appetite for BriaCell Therapeutics shares which in turn could have impacted BriaCell Therapeutics's share price.

BriaCell Therapeutics share price volatility

Over the last 12 months, BriaCell Therapeutics's shares have ranged in value from as little as $2.8149 up to $12.47. A popular way to gauge a stock's volatility is its "beta".

BCTX.US volatility(beta: 1.38)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BriaCell Therapeutics's is 1.3805. This would suggest that BriaCell Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

BriaCell Therapeutics overview

BriaCell Therapeutics Corp. , an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site